| INTRODUC TI ON
The presence of a skin-brain connection, so that alterations detected on the skin might inform on specific neurogenerative processes underlying Parkinson's disease and Alzheimer's disease (AD), is attracting increasing interest (Clos, Kayed, & Lasagna-Reeves, 2012) . Indeed, the biological processes underlying neurodegenerative diseases are complex, and the limited availability of suitable neuronal models for neurodegenerative research has hindered the understanding of the biological pathways involved in the disease initiation and evolution, as well as the identification of potential therapeutic targets.
Several reports have documented deficits of episodic memory in subjects who will develop AD or other neuropsychiatric disorders prior to diagnostically significant cognitive changes. Using data collected within the Twins UK study, which is a volunteer twin registry representative to the broader UK population regarding disease-related and lifestyle characteristics (Andrew et al., 2001) , our group has recently reported an association between short leucocyte telomere length (LTL) and impaired episodic memory (Valdes et al., 2010) . This association remained significant after adjustment for chronological age, suggesting that LTL might contribute to characterize the insidious transition from normal ageing to dementia, identifying people within the general population at increased risk of neuropsychiatric disorders because of a faster evolution of biological ageing.
Neurons are long-living postmitotic cells, which share several features with epidermal melanocytes, including a common embryological origins (Slominski, Tobin, Shibahara, & Wortsman, 2004) .
Similarly to episodic memory, total body naevus count declines with ageing and we previously documented that shorter LTL is associated with lower number of naevi, even after adjustment for chronological age (Bataille et al., 2007) . This evidence suggests that shared biological ageing pathways, captured by the measure of LTL, might influence both the evolution of neurodegenerative diseases underlying AD and the replicative potential within a naevus clone.
Based on this background, we used two independent samples from the Twins UK population to explore the relationship between naevus count and episodic memory, as well as whether this association could be explained, at least in part, by biological ageing (as assessed by LTL). The first (discovery) sample included 321 participants with measures of episodic memory function available in 1999 and 2009, and whole body naevus count assessed at baseline (Table 1) (Table 1 ). Both samples included participants free of overt dementia or cognitive impairment. A naevus was defined as a melanocytic lesion ≥2 mm in diameter to avoid any confusion with ephelides, and the protocol used for whole body naevus counting has been validated in the previous studies (Bataille et al., 1996 (Bataille et al., , 1998 . The paired associates learning (PAL) test (adjusted errors at eight boxes), which is part of the computerized CANTAB cognitive test battery (Robbins et al., 1994) , was used to assess episodic memory function. This test was selected as previous reports documented its capacity to detect memory changes predictive of AD and to provide a reliable estimate of memory changes in follow-up studies (Barnett, Blackwell, Sahakian, & Robbins, 2016) . Characteristics of the test and the method used for its administration were described in Steves et al.
Significance
The results of our study suggest that shared biological ageing pathways might control melanocyte biology and the process of neurodegeneration leading to memory decline.
The limited availability of suitable neuronal models to study the biological alterations underlying neurodegenerative diseases has precluded identification of potential therapeutic targets. Our results suggest that melanocytes and neurons might preserve common biological regulations in postnatal life and support the use of readily available melanocytes from the skin to shed light on the complex biology underlying neurodegenerative diseases. TA B L E 1 Clinical characteristics of the study population in the discovery and replication samples (Steves, Jackson, & Spector, 2013) . Mean leucocyte terminal restriction fragment length was used as a measure of LTL and assessed by the Southern blot method, as previously described (Bataille et al., 2007) . Ethics Committee approval for the Twins UK study was obtained from the Guy's and St Thomas Hospital NHS Trust, London. Subjects were not aware of the hypotheses being tested in this study at the time of recruitment.
In the discovery sample, change in PAL score for the periods 1999-2009 conditional on earlier PAL score was calculated by regressing the PAL follow-up score on the earlier PAL measure, saving and standardizing the residuals. Subsequently, we implemented a series of generalized estimating equations (GEE) to fit populationaveraged panel-data (i.e., pairs of twins) models with unstructured within-group correlation for the association of (a) baseline naevus count with memory function both at baseline and follow-up, (b)
baseline naevus count and changes in episodic memory, (c) LTL and naevus count at baseline and d) LTL and episodic memory. Normal distribution of the dependent continuous variables was graphically inspected with histograms and distributional plots (i.e., percentilepercentile plots). Variables that deviated from normality were transformed with the natural logarithm before entering the GEE analysis.
Results from the GEE analysis are presented as coefficients (β) and 95% confidence intervals (CI). To explore the proportion of the association between baseline naevus count and change in PAL explained by chronological or biological age, we included age and LTL, separately and in combination, in the models exploring the relationship between baseline naevus count and PAL residuals. The GEE analysis for the association between naevus count and PAL score was re- 
0.041
Note. Associations were established using generalized estimating equations.
TA B L E 3 Unadjusted and multiadjusted association between (a) baseline naevus count and changes in PAL in the discovery sample, and (b) naevus count and PAL test in the replication sample naevus count and PAL score was confirmed using the cross-sectional data available in the replication sample (β = −0.003; 95% CI −0.006, for the faster impairment in episodic memory observed in subjects with shorter LTL in this and previous studies (Valdes et al., 2010) . In keeping with this hypothesis, several reports described associations between hippocampal volume and LTL (King et al., 2014; Nilsonne, Tamm, Mansson, Akerstedt, & Lekander, 2015) . Like episodic memory, loss and degeneration of skin melanocytes determine a progressive decline in naevus count from the third decade of life and we previously documented that a lower total body naevus count is associated with shorter LTL (Bataille et al., 2007) . Taken together, this evidence suggests that the rate of decline in naevus count might help identification of people within the general population with altered regulation of biological ageing pathways, thus with a greater risk of hippocampal degeneration, episodic memory decline and, ultimately, neurodegenerative diseases. This is confirmed by genetic studies
showing that single nucleotide variants or epigenetic modifications in the region of TERT are associated with naevus count (Roos et al., 2017 ) and the risk of Alzheimer's disease (Zhan et al., 2015) .
Our study has several strengths. The availability of robust memory measures assessed at two different time points 10 years apart reduces the risk of learning effects, often complicating the interpretation of changes in cognitive function observed in longitudinal studies. Previous reports have validated the PAL tests for the assessment of episodic memory deficits, showing its ability to detect early memory changes predictive of AD risk. LTL was measured using terminal restriction fragment, which is currently considered the gold standard method for LTL assay. Finally, the work previously published by our group on the relationship of LTL with episodic memory as well as with naevus count increases the robustness of our results. Among limitations, while the association between naevus count and memory function was replicated in two independent samples, the size of both samples was relatively small.
Also, while several reports have now demonstrated that telomere length is highly synchronized between different cells and tissues at any age (Butler et al., 1998) , telomeres were measured in peripheral leucocytes and not directly on melanocytes and/or neurons.
In conclusion, the inverse association between naevus count and risk of episodic memory decline observed in our study suggests that a faster age-related decline in naevus count might help identification of people with faster evolution of biological ageing, and thus at greater risk of neuropsychiatric disorders. Also, our findings suggest 
